Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas

Blood

Volumn 90, Issue 1, 1997, Pages 313-322

  Ometto, Lucia ^b   Menin, Chiara ^b   Masiero, Sara ^b   Bonaldi, Laura ^b   Del Mistro, Annarosa ^b   Cattelan, Anna Maria ^b   D'Andrea, Emma ^b   De Rossi, Anita ^a   Chieco Bianchi, Luigi ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHADENOPATHY; LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS STRAIN;

EID: 0030920229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.313     Document Type: Article

References (41)

1. Levine AM: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 85:1382, 1993
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary M, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PC, Knowles DM, Mason DY, Muller-Harmelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
3. Beral V, Petterman T, Berkelman R, Jaffe H: AIDS-associated non-Hodgkin lymphoma. Lancet 337:805, 1991
4. Shibata M, Wiess LM, Nathwani BN, Brynes RK, Levine AM: Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77:1527, 1991
5. Pelicci PG, Knowles DM, Arlin ZA, Wieczorek R, Luciw P, Dina D, Basilico C, Dalla Favera R: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunodeficiency syndrome-related lymphoproliferative disorders. Implication for lymphomagenesis. J Exp Med 164:2049, 1986
6. Saglio G, Foa R, Guerrasio A, Di Celle PF, Palestro G, Sinicco A, Gobbi M, Gavosto F: Immunoglobulin and myc gene structure in lymph node biopsies from HIV-positive patients with LAS and lymphoma. Cancer Detect Prev 14:359, 1990
7. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 82:619, 1993
8. Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds): Virology, vol 2. Philadelphia, PA, Lippincott-Raven, 1996, p 2397
9. Dambaugh T, Hennessy K, Chamnankit L, Kieff E: U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632, 1984
10. Miller WE, Edwards RH, Walling DM, Raab Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75:2729, 1994
11. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N: The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: Strain variation, genetic recombination, and transcriptional expression. J Virol 68:7918, 1994
12. Menin C, Ometto L, Veronesi A, Roncella S, Corneo B, Montagna M, Coppola V, Veronese ML, Indraccolo S, Amadori A, De Rossi A, Ferrarini M, Chieco-Bianchi L, D' Andrea E: Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and hu-scid mouse tumors. Mol Cell Probes 10:443, 1995
13. Rickinson AB, Young LS, Rowe M: Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus transformed B cells. J Virol 61:1310, 1987
14. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA: Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 78:3004, 1991
15. Shibata M, Wiess LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM: Epstein-Barr virus associated non-Hodgkin's lymphoma in patients with the human immunodeficiency virus. Blood 81:2102, 1993
16. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA: Coinfection with A-and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643, 1990
17. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM: Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol 75:431, 1994
18. Yao QY, Tierney RJ, Croom-Carter D, Dukers D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB: Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 70:4884, 1996
19. Dolcetti R, Gloghini A, De Vita S, Vaccher E, De Re V, Tirelli U, Carbone A, Boiocchi M: Characteristics of EBV-infected cells in HIV-related lymphadenopathy: Implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. Int J Cancer 63:652, 1995
20. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 11:1674, 1993
21. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 49:2112, 1982
22. Kallio P, Syrjanen S, Tervahauta A, Syrjanen K: A simple method for isolation of DNA from formalin-fixed paraffin-embededd samples for PCR. J Virol Methods 35:39, 1991
23. Veronesi A, Coppola V, Veronese ML, Menin C, Bruni L, D'Andrea E, Mion M, Amadori A, Chieco-Bianchi L: Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected SCID mice. II. Role of host and donors factors in tumor generation. Int J Cancer 59:676, 1994
24. Menin C, Ometto L, Veronesi A, Montagna M, Coppola V, Veronese ML, Indraccolo S, Bruni L, Corneo B, Amadori A, De Rossi A, Chieco-Bianchi L, D'Andrea E: Dominance of a single Epsterin-Barr virus strain in SCID-mouse tumors induced by injection of peripheral blood mononuclear cells from healthy human donors. Virus Res 36:215, 1995
25. Ometto L, Zanotto C, Maccabruni A, Caselli D, Truscia D, Giaquinto C, Ruga E, Chieco-Bianchi L, De Rossi A: Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 9:427, 1995
26. Miller G, Coope D, Niederman J, Pagano J: Biological properties and viral surface antigens of Burkitt lymphoma and mononucleosis-derived strains of Epstein-Barr virus related from transformed marmoset cells. J Virol 18:1071, 1976
27. Fenwald S, van Santen V, Kieff E: Nucleotide sequence of an mRNA transcribed in latent growth transforming virus infection indicates that it may encode a membrane protein. J Virol 51:411, 1984
28. Brooks L, Yao QY, Rickinson AB, Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689, 1992
29. Longnecker R, Miller CL: Regulation of Epstein-Barr virus latency by latent membrane protein 2. Trends Microbiol 4:38, 1996
30. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303, 1993
31. Joab J, Triki H, De Saint Martin J, Perricaudet M, Nicolas JC: Detection of anti-Epstein-Barr virus transactivator (ZEBRA) antibodies in sera from patients with the human immunodeficiency virus. J Infect Dis 163:53, 1991
32. Brousset P, Drouet E, Schlaifer D, Icart J, Payen C, Meggetto F, Marchou B, Massip P, Delsol G: Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's limphoma in relation to CD4 cell number and antibody titres to EBV. AIDS 8:583, 1994
33. Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DH, Raab-Traub N: Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 171:1122, 1995
34. Yao QY, Tierney RJ, Croom-Carter D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB: Isolation of intertypic recombinants of Epstein-Barr virus from T-cell immunocompromised individuals. J Virol 70:4895, 1996
35. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, Dalla Favera R: Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodificiency associated-lymphoma. Blood 77:1092, 1991
36. Roue M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV positive lymphomas in man. J Exp Med 173:147, 1991
37. Hernandez AM, Shibata D: Epstein-Barr virus-associated non-Hodgkin's lymphoma in HIV-infected patients. Leuk Lymphoma 16:217, 1995
38. Cohen J, Wang F, Mannick J, Kieff E: Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558, 1989
39. Mosialos G, Birkenbach M, VanArsdale T, Ware C, Yalamanchili R, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
40. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
41. Pantaleo G, Graziosi C, Fauci AS: The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS 7:S19, 1993 (suppl)